INSOMNIA is the #7 most commonly reported adverse reaction for DESVENLAFAXINE SUCCINATE, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 1,556 FDA adverse event reports linking DESVENLAFAXINE SUCCINATE to INSOMNIA. This represents approximately 2.9% of all 53,036 adverse event reports for this drug.
Patients taking DESVENLAFAXINE SUCCINATE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA1,556 of 53,036 reports
INSOMNIA is a less commonly reported adverse event for DESVENLAFAXINE SUCCINATE, but still significant enough to appear in the safety profile.
Other Side Effects of DESVENLAFAXINE SUCCINATE
In addition to insomnia, the following adverse reactions have been reported for DESVENLAFAXINE SUCCINATE:
INSOMNIA has been reported as an adverse event in 1,556 FDA reports for DESVENLAFAXINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with DESVENLAFAXINE SUCCINATE?
INSOMNIA accounts for approximately 2.9% of all adverse event reports for DESVENLAFAXINE SUCCINATE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking DESVENLAFAXINE SUCCINATE?
If you experience insomnia while taking DESVENLAFAXINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.